Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Cassoni P, Arena V, Bustreo S, Faletti R, Rondi N, Morino M, Ricardi U. Franco P, et al. Among authors: gallio e. Med Oncol. 2016 Jul;33(7):72. doi: 10.1007/s12032-016-0789-x. Epub 2016 Jun 8. Med Oncol. 2016. PMID: 27277756
Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.
Franco P, Arcadipane F, Trino E, Gallio E, Martini S, Iorio GC, Piva C, Moretto F, Ruo Redda MG, Verna R, Tseroni V, Bona C, Pozzi G, Fiandra C, Ragona R, Bertetto O, Ricardi U. Franco P, et al. Among authors: gallio e. Clin Transl Radiat Oncol. 2018 Jun 11;11:33-39. doi: 10.1016/j.ctro.2018.06.002. eCollection 2018 Jun. Clin Transl Radiat Oncol. 2018. PMID: 29928706 Free PMC article.
Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.
Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Trino E, Cassoni P, Arena V, Baccega M, Racca P, Faletti R, Rondi N, Morino M, Ricardi U. Franco P, et al. Among authors: gallio e. Cancer Invest. 2018;36(5):279-288. doi: 10.1080/07357907.2018.1479413. Epub 2018 Jun 28. Cancer Invest. 2018. PMID: 29953269
Radiation therapy for oligometastatic oropharyngeal cancer.
Martini S, Arcadipane F, Franco P, Iorio GC, Bartoncini S, Gallio E, Guarneri AS, Ricardi U. Martini S, et al. Among authors: gallio e. BJR Case Rep. 2020 Feb 12;6(1):20190021. doi: 10.1259/bjrcr.20190021. eCollection 2020 Mar. BJR Case Rep. 2020. PMID: 32201599 Free PMC article.
Adoption of Expansion Margins to Reduce the Dose Received by the Coronary Arteries and the Risk of Cardiovascular Events in Lymphoma Patients.
De Luca V, Gallio E, Bartoncini S, Giglioli FR, Sardo A, Cavallin C, Iorio GC, Orlandi E, Parise R, Palladino C, Buonavita A, Fiandra C, Levis M, Ricardi U. De Luca V, et al. Among authors: gallio e. Pract Radiat Oncol. 2021 Jan-Feb;11(1):66-73. doi: 10.1016/j.prro.2020.06.005. Epub 2020 Jun 19. Pract Radiat Oncol. 2021. PMID: 32565414
Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial.
Arcadipane F, Silvetti P, Olivero F, Gastino A, De Luca V, Mistrangelo M, Cassoni P, Racca P, Gallio E, Lesca A, Fiandra C, Ricardi U, Franco P. Arcadipane F, et al. Among authors: gallio e. Cancers (Basel). 2020 Nov 9;12(11):3306. doi: 10.3390/cancers12113306. Cancers (Basel). 2020. PMID: 33182445 Free PMC article.
27 results